Polymorphism

Men

OR

(95% CI)

p

Women

OR

(95% CI)

p

N0

n (%)

N1 - N3

n (%)

N0

n (%)

N1 - N3

n (%)

VEGF

−634C > G

n = 87

n = 79

n = 35

n = 17

GG

45 (51.7)

43 (54.4)

1.00

0.82

16 (45.7)

8 (47.1)

1.00

0.99

GC

33 (37.9)

30 (38)

0.95

(0.50 - 1.82)

17 (48.6)

8 (47.1)

0.94

(0.29 - 3.11)

CC

9 (10.3)

6 (7.6)

0.70

(0.23 - 2.13)

2 (5.7)

1 (5.9)

1.00

(0.08 - 12.76)

GC+CC

42 (48.3)

36 (45.6)

0.90

(0.49 - 1.65)

0.73

19 (54.3)

9 (52.9)

0.95

(0.30 - 3.03)

0.93

VEGF

−2578C > A

n = 87

n = 79

n = 35

n = 17

CC

25 (28.7)

25 (31.6)

1.00

0.18

4 (11.4)

8 (47.1)

10.00

(1.44 - 69.26)

CA

40 (46)

43 (54.4)

1.07

(0.53 - 2.17)

21 (60)

7 (41.2)

1.67

(0.29 - 9.52)

0.02

AA

22 (25.3)

11 (13.9)

0.50

(0.20 - 1.24)

10 (28.6)

2 (11.8)

1.00

CA+ AA

62 (71.3)

54 (68.3)

0.87

(0.45 - 1.69)

0.68

31 (88.6)

9 (52.9)

0.14

(0.035 - 0.60)

0.01

VEGF +936C > T

n = 87

n = 79

n = 35

n = 17

CC

60 (69)

55 (69.6)

1.00

0.77

22 (62.9)

11 (64.7)

1.00

0.39

CT

23 (26.4)

22 (27.9)

1.04

(0.52 - 2.08)

12 (34.3)

4 (23.5)

0.67

(0.17 - 2.55)

TT

4 (4.6)

2 (2.5)

0.55

(0.10 - 3.10)

1 (2.9)

2 (11.8)

4.00

(0.33 - 49.08)

CT + TT

27 (31)

24 (30.4)

0.97

(0.50 - 1.88)

0.93

13 (37.1)

6 (35.3)

0.92

(0.28 - 3.09)

0.90